These are updated guidelines which supersede the original version published in 2004. This work has been endorsed by the Clinical Services and Standards Committee of the British Society of Gastroenterology (BSG) under the auspices of the esophageal section of the BSG.
The original guidelines have undergone extensive revision by the 16 members of the Guideline Development Group with representation from individuals across all relevant disciplines, including the Heartburn Cancer UK charity, a nursing representative and a patient representative.
Professor Stephen Attwood and colleagues from the United Kingdom appraised, The methodological rigor and transparency of the guideline development processes were appraised using the revised Appraisal of Guidelines for Research and Evaluation (AGREE II) tool.
Dilatation of the esophagus is a relatively high-risk intervention, and is required by an increasing range of disease states.
Moreover, there is scarcity of evidence in the literature to guide clinicians on how to safely perform this procedure.
These guidelines deal specifically with the dilatation procedure using balloon or bougie devices as a primary treatment strategy for non-malignant narrowing of the esophagus.
The use of stents is outside the remit of this paper.
However, for cases of dilatation failure, alternative techniques—including stents—will be listed.
The team reported that the guideline is divided into several subheadings, including patient preparation, the dilatation procedure, aftercare, and disease-specific considerations.
The research team performed a systematic literature search.
Professor Attwood's team concludes, "We used The Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool to evaluate the quality of evidence and decide on the strength of recommendations made."